State Key Laboratory of Natural Medicines, China Pharmaceutical University, No. 24 Tongjia Lane, Nanjing, 210009, China.
Guangdong Efong Pharmaceutical Co., Ltd., Foshan, 528244, China.
J Pharm Biomed Anal. 2019 May 30;169:1-10. doi: 10.1016/j.jpba.2019.02.030. Epub 2019 Feb 19.
There is an increasing focus on the quality consistency evaluation of dispensing granule in traditional Chinese medicines (TCMs). According to the guideline from Chinese Pharmacopoeia Commission, the substantial equivalence of dispensing granule and traditional decoction should be determined, and the chromatographic fingerprint has been recommended as a comprehensive qualitative approach to assess the quality consistency between dispensing granule and traditional decoction. However, a high-degree chemical similarity does not equal a bioequivalence. Attempting to realize the quality evaluation by integrating chemical consistency and bioequivalence, we herein proposed a totality-of-the-evidence approach based on clustering analysis and equivalence evaluation taking the dispensing granule and traditional decoction of Scutellariae Radix (SR) as a typical case. Chemical fingerprints were developed by high performance liquid chromatography coupled with photodiode array detector and quadrupole time-of-flight mass spectrometry (HPLC-PDA/QTOF-MS). Subsequently, a feature selection strategy, integrated linear and nonlinear correlation analysis, was carried out to assess the correlation between chemical profiles and biological activities. Finally, quality consistency between the dispensing granule and the traditional decoction was determined by bioactive marker-guided hierarchical clustering analysis (HCA), k-means clustering method and bioequivalence evaluation. The available evidence suggested that not all the dispensing granule of SR were sufficiently similar to the traditional decoction. This study provides an applicable methodology for quality consistency evaluation of dispensing granule and traditional decoction in TCMs.
越来越关注中药配方颗粒的质量一致性评价。根据中国药典委员会的指导原则,应确定配方颗粒与传统汤剂的实质性等效性,并推荐色谱指纹图谱作为一种综合定性方法,以评估配方颗粒与传统汤剂之间的质量一致性。然而,高度的化学相似性并不等同于生物等效性。我们试图通过整合化学一致性和生物等效性来实现质量评价,以黄芩配方颗粒和传统汤剂为例,提出了一种基于聚类分析和等效性评价的全证据方法。采用高效液相色谱-光电二极管阵列检测-四极杆飞行时间质谱联用(HPLC-PDA/QTOF-MS)建立了化学指纹图谱。随后,采用线性和非线性相关分析相结合的特征选择策略,评估了化学特征与生物活性之间的相关性。最后,通过基于生物活性标志物的层次聚类分析(HCA)、k-均值聚类方法和生物等效性评价,确定了配方颗粒和传统汤剂之间的质量一致性。现有证据表明,并非所有黄芩配方颗粒都与传统汤剂足够相似。本研究为中药配方颗粒和传统汤剂的质量一致性评价提供了一种可行的方法。